Search Results - john+chute

3 Results Sort By:
2016-518: Inhibition of Protein Tyrosine Phosphatase-Sigma for Hematopoietic Regeneration
Inhibition Of Protein Tyrosine Phosphatase - Sigma For Hematopoietic RegenerationSUMMARYUCLA Researchers have identified a novel pharmacological target for hematopoietic stem cell regeneration. They have developed small molecule inhibitors against the target and shown that the inhibitors cause rapid stem cell regeneration.BACKGROUNDDepletion of white...
Published: 7/19/2023   |   Inventor(s): John Chute, Michael Jung, Emelyne Diers
Keywords(s): Autoimmune, Hematology, Inflammatory Diseases, iPS/stem cells, Oncology
Category(s): Therapeutics > Autoimmune, Therapeutics > Oncology, Therapeutics > Hematology, Therapeutics > Inflammation And Inflammatory Diseases, Therapeutics > Stem Cells And Regenerative Medicine > Ips Stem Cells
2015-365 TARGETING PROTEIN TYROSINE PHOSPHATASE-SIGMA TO AUGMENT HEMATOPOIETIC RECONSTITUTION
Targeting Protein Tyrosine Phosphatase-Sigma to Augment Hematopoietic ReconstitutionSUMMARYUCLA researchers from the Department of Medicine have developed a novel technique for inducing increased hematopoietic recovery after HSC transplantation by targeting the protein tyrosine phosphatase-sigma (PTP-sigma) pathway.BACKGROUNDReceptor tyrosine kinases...
Published: 7/19/2023   |   Inventor(s): John Chute
Keywords(s): Hematology, Life Science Research Tools, Targets And Assays, Therapeutics & Vaccines
Category(s): Life Science Research Tools, Diagnostic Markers > Targets And Assays, Therapeutics, Therapeutics > Hematology
Targeted Inhibition of Human Multiple Myeloma
Case 2018-175UCLA researchers in the Department of Medicine have discovered a novel mechanism involving Eph receptor/ephrin ligand interaction, that regulates human multiple myeloma growth and repopulation in vivo.BACKGROUNDMultiple myeloma (MM) is a plasma cell malignancy often accompanied by bone osteolytic lesions. Despite standard care with high...
Published: 7/19/2023   |   Inventor(s): John Chute, Joshua Sasine
Keywords(s): Hematology, Therapeutics & Vaccines
Category(s): Therapeutics, Therapeutics > Hematology